3 ms·
How can I “bootstrap” this from start to finish assuming money isn’t an issue. Money is an issue, and you'll have costs that software startups don't have to co
by ilamont 7y ago
How can I “bootstrap” this from start to finish assuming money isn’t an issue.
Money is an issue, and you'll have costs that software startups don't have to contend with, such as renting or building out lab space, and eventually doing trials. You'll also need a far longer runway owing to the typical R&D, trial, and approval timelines.
I know of one biopharma startup that "bootstrapped" by doing R&D for other pharma companies while developing their own products, but that required contracts worth millions.
Then there's the "virtual pharma" movement, which AFAIK hasn't really created much value. They have a few executive and science positions, but don't own lab space and basically outsource almost all development (using funds from investors) with the hope that they'll have something promising enough a few years later to justify acquisition by a larger company.
- WannabeBioHackr 7y agoThe reason why I used bootstrapped in quotations was probably not made clear. There is an abundance of SaaS companies that one can duck tape together to create a “full-stack” solution for others. Does that exist? Is there a scenario someone could map out in biotech? An example of a company I think about is Emerald Cloud Labs for certain experiments. How would that work in pharma?